Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-methyl-5-(2-fluorophenyl)-7-chloro-1,3-dihydro-2h-(1,4)benzodiazepin-2-one
2. Fludiazepan
3. Id 540
1. Erispan
2. 3900-31-0
3. Fludiazepamum [inn-latin]
4. 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one
5. Id-540
6. 7-chloro-5-(2-fluorophenyl)-1-methyl-3h-1,4-benzodiazepin-2-one
7. Chebi:31618
8. 7f64a2k16z
9. Fludiazepamum
10. Fludiazepam [inn:jan]
11. Id 540
12. Erispan (tn)
13. Brn 0686115
14. Unii-7f64a2k16z
15. Dea No. 2759
16. 7-chloro-5-(2-fluorophenyl)-1-methyl-1h-1,4-benzodiazepin-2(3h)-one
17. 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-2h-1,4-benzodiazepin-2-one
18. 7-chloro-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2h-1,4-benzodiazepin-2-one
19. Fludiazepam [mi]
20. Fludiazepam [inn]
21. Fludiazepam [jan]
22. Fludiazepam (jp17/inn)
23. 2h-1,4-benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-
24. 2h-1,4-benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-
25. Fludiazepam [mart.]
26. Fludiazepam [who-dd]
27. 5-24-04-00320 (beilstein Handbook Reference)
28. Chembl13291
29. Schembl156039
30. Dtxsid00192277
31. Db01567
32. Ro-5-3438
33. 2h-1,4-benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(o-fluorophenyl)-1-methyl-
34. D01354
35. 900f310
36. Q3486981
37. 7-chloro-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2h-1,4-benzodiazepin-2-one #
38. 7-chloro-5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1h-1,4-benzodiazepin-2-one
| Molecular Weight | 302.73 g/mol |
|---|---|
| Molecular Formula | C16H12ClFN2O |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 1 |
| Exact Mass | 302.0622189 g/mol |
| Monoisotopic Mass | 302.0622189 g/mol |
| Topological Polar Surface Area | 32.7 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 442 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used for the short-term treatment of anxiety disorders.
Fludiazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Fludiazepam accumulates primarily in the cortex and thalamus.
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N - Nervous system
N05 - Psycholeptics
N05B - Anxiolytics
N05BA - Benzodiazepine derivatives
N05BA17 - Fludiazepam
Hepatic.
Fludiazepam has similar action to diazepam, but binds with four times more affinity to benzodiazepine receptors than diazepam.
ABOUT THIS PAGE
A Fludiazepam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fludiazepam, including repackagers and relabelers. The FDA regulates Fludiazepam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fludiazepam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fludiazepam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fludiazepam supplier is an individual or a company that provides Fludiazepam active pharmaceutical ingredient (API) or Fludiazepam finished formulations upon request. The Fludiazepam suppliers may include Fludiazepam API manufacturers, exporters, distributors and traders.
click here to find a list of Fludiazepam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fludiazepam written confirmation (Fludiazepam WC) is an official document issued by a regulatory agency to a Fludiazepam manufacturer, verifying that the manufacturing facility of a Fludiazepam active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fludiazepam APIs or Fludiazepam finished pharmaceutical products to another nation, regulatory agencies frequently require a Fludiazepam WC (written confirmation) as part of the regulatory process.
click here to find a list of Fludiazepam suppliers with Written Confirmation (WC) on PharmaCompass.
Fludiazepam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fludiazepam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fludiazepam GMP manufacturer or Fludiazepam GMP API supplier for your needs.
A Fludiazepam CoA (Certificate of Analysis) is a formal document that attests to Fludiazepam's compliance with Fludiazepam specifications and serves as a tool for batch-level quality control.
Fludiazepam CoA mostly includes findings from lab analyses of a specific batch. For each Fludiazepam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fludiazepam may be tested according to a variety of international standards, such as European Pharmacopoeia (Fludiazepam EP), Fludiazepam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fludiazepam USP).
LOOKING FOR A SUPPLIER?
